J. Maity et al. / Tetrahedron Letters 56 (2015) 4780–4783
4783
0 0 0
40. Procedure for the synthesis of (R)-2-amino-4-(4 -N,N-dimethylamino-1 ,8 -
2
1
2
2
naphthalimido)-N -(tert-butoxycarbonyl)butanoic acid (10): Compound
8
(0.266 g, 1.1 mmol) was kept under a nitrogen atmosphere in a three neck
round bottom flask fitted with water condenser. Dioxane (25 mL) was added
through a septum whereupon the mixture was heated at reflux and stirred
2
2
vigorously. Boc-
D-Dab-OH (9, 0.218 g, 1.0 mmol) was dissolved in an aqueous
solution (5 mL) containing NaHCO
3
(0.42 g, 5 mmol) and added into the
reaction mixture. The reaction mixture was heated at reflux for 1 h. TLC
showed complete consumption of the amino acid, the mixture was
concentrated under reduced pressure and water (60 mL) was added. The
2
2
water phase was washed with Et
pH 3 in an ice-bath whereupon a yellow precipitate formed. The aqueous phase
2
O (2 ꢀ 60 mL) and acidified with 2 N HCl till
2
was extracted with DCM (3 ꢀ 80 mL) and the combined organic layers were
2
2
2
2 4
dried over Na SO , filtered and concentrated under reduced pressure. The
crude product was purified by column chromatography (40–50% ethyl acetate
in hexane containing 0.1% AcOH) to afford compound 10 (0.27 g, 66%). R = 0.2
ꢁ40.6 (c 0.032, MeOH); H NMR
): d = 8.49 (d, J = 7.2 Hz, 1H), 8.39 (d, J = 7.6 Hz, 1H), 8.36 (d,
J = 8.4 Hz, 1H), 7.58 (t, J = 8.0 Hz, 1H), 7.02 (d, J = 8.4 Hz, 1H), 5.52 (d, J = 7.6 Hz,
1H), 4.27–4.16 (m, 3H), 3.04 (s, 6H), 2.21–2.11 (m, 2H), 1.35 (s, 9H) ppm. 13
NMR (100.6 MHz, CDCl ): d = 174.6, 165.1, 164.6, 157.5, 156.0, 133.4, 131.9,
f
2
2
1
(50% ethyl acetate–hexane, 1% AcOH), [
(400 MHz, CDCl
a]
D
3
3
C
3
3
3
131.7, 130.5, 125.2, 125.0, 122.7, 114.2, 113.4, 80.4, 52.0, 44.9, 36.8, 30.8,
ꢁ
28.5 ppm. HRMS (ESI-TOF) (m/z): calcd for C23
found 440.1827.
H
26
N
3
O
6
[MꢁH] 440.1827,
3
0
0
0
41. Procedure for the synthesis of (R)-2-amino-4-(4 -N,N-dimethylamino-1 ,8 -
2
3
3
naphthalimido)-N -(9-fluorenylmethoxycarbonyl)butanoic
acid
(11):
Compound 10 (0.12 g, 0.27 mmol) was dissolved in DCM (3 mL). Cold
trifluoroacetic acid (3 mL) was added over 5 min and the reaction mixture
was stirred for 2 h. The reaction mixture was concentrated to dryness under
reduced pressure and excess TFA removed by coevaporation with chloroform
(3 ꢀ 10 mL). The crude product was dried under vacuum overnight then
3
3
3
8. Procedure for synthesis of (R)-2-amino-(9-fluorenylmethoxycarbonyl)amino-
3
dissolved in water (4 mL) containing NaHCO (0.114 g, 1.35 mmol). Dioxane
0
0
3
-(4 -acetamido-[1,1 -biphenyl]-4-yl)propanoic acid (6): Compound
64 mg, 0.25 mmol) was dissolved in mixture of tetrahydrofuran and
ethylene glycol (10:1, 15 mL) at rt. N-(9-Fluorenylmethoxycarbonyl)-4-
bromo- -phenylalanine (5, 96 mg, 0.21 mmol) was added and the mixture
was kept stirring. PdCl (10 mol %, 4 mg) was added and nitrogen was bubbled
through the reaction mixture for 15 min. Na CO (66 g, 0.62 mmol) was then
4
(10 mL) was added, followed by Fmoc-OSu (0.101 g, 0.3 mmol). The reaction
mixture was stirred at 0 °C for 2 h. When the TLC showed complete
consumption of the starting material the reaction mixture was diluted with
(
a
D
water (20 mL). The aqueous layer was washed with Et
acidified with 6 N HCl to adjust the pH to 6. The product was extracted with
4
SO ,
2
O (2 ꢀ 20 mL) and
2
2
3
DCM (3 ꢀ 25 mL) and the combined organic layers were dried over Na
2
added into the reaction mixture whereupon the flask was filled with nitrogen
and heated at 66 °C for 3 h. When the TLC showed completion of the reaction
water (20 mL) was added into the reaction mixture which was then extracted
with ethyl acetate (3 ꢀ 30 mL). The combined organic layers were washed with
filtered and concentrated under reduced pressure. The crude compound was
purified by column chromatography (0.5–1% MeOH in DCM containing 0.1%
AcOH) to afford compound 11 (0.116 g, 71%). R
f
= 0.6 (2.5% MeOH–DCM, 1%
): d = 8.51 (d,
22
1
AcOH), [
a
]
D
ꢁ8.0 (c 0.05, MeOH); H NMR (400 MHz, CDCl
3
brine-water (1:1, 2 ꢀ 25 mL), dried over Na
2
SO
4
and concentrated to dryness
J = 6.8 Hz, 1H), 8.41 (d, J = 8.4 Hz, 1H), 8.35 (d, J = 8.4 Hz, 1H), 7.67 (d, J = 7.2 Hz,
2H), 7.59–7.52 (m, 3H), 7.31 (t, J = 7.2 Hz, 2H), 7.23 (t, J = 7.2 Hz, 2H), 7.00 (d,
J = 8.0 Hz, 1H), 5.96 (d, J = 8.0 Hz, 1H), 4.35–4.31 (m, 1H), 4.29–4.19 (m, 4H),
under reduced pressure. The crude product was purified by column
chromatography (2–3% MeOH in DCM containing 0.1% AcOH) to afford
2
7
compound 6 (87 mg, 81%). R
f
= 0.25 (5% MeOH–DCM, 1% AcOH), [
O), H NMR (400 MHz, CD OD): d = 7.67 (d, J = 6.8 Hz, 2H), 7.52–7.44
m, 6H), 7.37 (d, J = 7.6 Hz, 3H), 7.28–7.12 (m, 5H), 4.36 (dd, J = 7.6, 4.8 Hz, 1H),
a
]
D
ꢁ10.0
4.13 (t, J = 7.2 Hz, 1H), 3.03 (s, 6H), 2.34–2.25 (m, 1H), 2.19–2.11 (m, 1H) ppm.
1
13
(
c 0.05, H
2
3
3
C NMR (100.6 MHz, CDCl ): d = 174.0, 165.2, 164.8, 157.7, 156.2, 144.0, 141.4,
(
133.6, 132.1, 131.8, 130.6, 127.8, 127.3, 125.4, 125.1, 125.0, 122.6, 120.1, 113.9,
4
4
.23–4.19 (m, 1H), 4.12–4.08 (m, 1H), 4.05–4.01 (m, 1H), 3.16 (dd, J = 14.0,
113.3, 67.4, 52.2, 47.2, 44.9, 36.8, 31.1 ppm. HRMS (ESI-TOF) (m/z): calcd for
13
ꢁ
.8 Hz, 1H), 2.82 (dd, J = 14.0, 9.6 Hz, 1H), 2.04 (s, 3H) ppm.
C
NMR
(
100.6 MHz, CD
3
OD): d = 171.7, 158.4, 145.3, 142.6, 140.3, 139.2, 137.9,
1
4
37.7, 130.9, 128.8, 128.2, 128.0, 127.7, 126.4, 126.3, 121.5, 120.9, 68.0, 56.9,
8.4, 38.4, 23.9 ppm. HRMS (ESI-TOF) (m/z): calcd for C32
H
27
2
N O
5
[MꢁH]ꢁ
3